Due to the fetoneonatal pathway it is possible to identify pregnant women with an increased risk of fetal growth restriction or pre-eclampsia in early stages (from 10th week of pregnancy). Women whose pregnancy is considered high-risk receives risk-adapted prenatal treatment as well as certain treatments for their newborn and infant until 1 year of age. The tasks of all involved persons are defined by standard operating procedures (SOP)
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Evaluation of patients' safety: maternal pre-eclampsia rate
Timeframe: through study completion, an average of 1 year and 7 months
Evaluation of patients' safety: newborn's birthweight adjusted by gestational age
Timeframe: through study completion, an average of 1 year and 7 months
Evaluation of patients' safety: maternal morbidity
Timeframe: through study completion, an average of 1 year and 7 months
Evaluation of patients' safety: infantil morbidity
Timeframe: through study completion, an average of 1 year and 7 months
Evaluation of patients' safety: Quality of life
Timeframe: through study completion, an average of 1 year and 7 months
Evaluation of patients' safety: attachment behavior
Timeframe: through study completion, an average of 1 year and 7 months
Evaluation of patient's access to treatment and satisfaction
Timeframe: through study completion, an average of 1 year and 7 months
claim of the health services
Timeframe: From admission to discharge, study inclusion to one year postpartum)
prohibition of employment
Timeframe: From admission to discharge, study inclusion to one year postpartum)
duration of unemployability
Timeframe: From admission to discharge, study inclusion to one year postpartum)